Belman Anita L, Krupp Lauren B, Olsen Cody S, Rose John W, Aaen Greg, Benson Leslie, Chitnis Tanuja, Gorman Mark, Graves Jennifer, Harris Yolander, Lotze Tim, Ness Jayne, Rodriguez Moses, Tillema Jan-Mendelt, Waubant Emmanuelle, Weinstock-Guttman Bianca, Casper T Charles
Department of Neurology, Stony Brook University, Stony Brook, New York; NYU Langone Multiple Sclerosis Comprehensive Care Center, New York, New York;
NYU Langone Multiple Sclerosis Comprehensive Care Center, New York, New York;
Pediatrics. 2016 Jul;138(1). doi: 10.1542/peds.2016-0120.
To describe the demographic and clinical characteristics of pediatric multiple sclerosis (MS) in the United States.
This prospective observational study included children and adolescents with MS. Cases were evaluated across 9 geographically diverse sites as part of the US Network of Pediatric MS Centers.
A total of 490 children and adolescents (324 girls, 166 boys) were enrolled; 28% developed symptoms before 12 years of age. The proportion of girls increased with age from 58% (<12 years) to 70% (≥12 years). Race and ethnicity as self-identified were: white, 67%; African American, 21%; and non-Hispanic, 70%. Most (94%) of the cases were born in the United States, and 39% had 1 or both foreign-born parents. Fifty-five percent of cases had a monofocal presentation; 31% had a prodrome (most frequently infectious), most often among those aged <12 years (P < .001). Children aged <12 years presented more commonly with encephalopathy and coordination problems (P < .001). Sensory symptoms were more frequently reported by older children (ie, those aged ≥12 years) (P < .001); 78% of girls had MS onset postmenarche. The initial Expanded Disability Status Scale score for the group was <3.0, and the annualized relapse rate was 0.647 for the first 2 years. Interval from symptom onset to diagnosis and from diagnosis to initiation of disease-modifying therapy was longer among those <12 years of age.
Pediatric MS in the United States is characterized by racial and ethnic diversity, a high proportion of children with foreign-born parents, and differences in clinical features and timing of treatment among those <12 years of age compared with older children.
描述美国儿童多发性硬化症(MS)的人口统计学和临床特征。
这项前瞻性观察性研究纳入了患有MS的儿童和青少年。作为美国儿童MS中心网络的一部分,在9个地理位置不同的地点对病例进行了评估。
共纳入490名儿童和青少年(324名女孩,166名男孩);28%在12岁之前出现症状。女孩的比例随着年龄增长从58%(<12岁)增加到70%(≥12岁)。自我认定的种族和族裔为:白人,67%;非裔美国人,21%;非西班牙裔,70%。大多数(94%)病例出生在美国,39%有1名或2名外国出生的父母。55% 的病例表现为单病灶;31% 有前驱症状(最常见的是感染性),最常见于年龄 <12岁的儿童中(P <.001)。年龄 <12岁的儿童更常出现脑病和协调问题(P <.001)。年龄较大的儿童(即≥12岁的儿童)更频繁地报告感觉症状(P <.001);78% 的女孩在月经初潮后发病。该组的初始扩展残疾状态量表评分为<3.0,前两年的年化复发率为0.647。年龄<l2岁的儿童从症状出现到诊断以及从诊断到开始疾病修饰治疗的间隔时间更长。
美国儿童MS的特点是种族和族裔多样性、有外国出生父母的儿童比例高,以及与年龄较大的儿童相比,<12岁儿童的临床特征和治疗时机存在差异。